A portable ultrasound sensor may enable earlier detection of breast cancer
The new system could be used at home or in doctors’ offices to scan people who are at high risk for breast cancer.
Cancer’s secret safety net
Researchers uncover a hidden mechanism that allows cancer to develop aggressive mutations.
Richard Hynes, a pioneer in the biology of cellular adhesion, dies at 81
Professor, mentor, and leader at MIT for more than 50 years shaped fundamental understandings of cell adhesion, the extracellular matrix, and molecular mechanisms of metastasis.
AI-generated sensors open new paths for early cancer detection
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
Study: High-fat diets make liver cells more likely to become cancerous
New research suggests liver cells exposed to too much fat revert to an immature state that is more susceptible to cancer-causing mutations.
A new immunotherapy approach could work for many types of cancer
Using new molecules that block an immune checkpoint, researchers showed they could stimulate a strong anti-tumor immune response.
MIT researchers find new immunotherapeutic targets for glioblastoma
A study profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking a treatment-resistant and deadly brain cancer.
A new way to deliver antibodies could make treatment much easier for patients
Therapeutic antibodies packaged into microparticles could be injected with a standard syringe, avoiding the need for lengthy and often uncomfortable infusions.
Prognostic tool could help clinicians identify high-risk cancer patients
Using a versatile problem-solving framework, researchers show how early relapse in lymphoma patients influences their chance for survival.
MIT chemists synthesize a fungal compound that holds promise for treating brain cancer
Preliminary studies find derivatives of the compound, known as verticillin A, can kill some types of glioma cells.
An improved way to detach cells from culture surfaces
The approach could transform large-scale biomanufacturing by enabling automated and contamination-conscious workflows for cell therapies, tissue engineering, and regenerative medicine.
Turning on an immune pathway in tumors could lead to their destruction
MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.
New nanoparticles stimulate the immune system to attack ovarian tumors
Targeted particles carrying the cytokine IL-12 can jump-start T cells, allowing them to clear tumors while avoiding side effects.
Startup’s tablets deliver cancer drugs more evenly over time
An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.
Engineered “natural killer” cells could help fight cancer
A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells.